Andrii Monastyrskyi

Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer

Víctor Quereda, Simon Bayle, Francesca Vena et al. · Cancer Cell · 2019 · 359 citations · Full text

Breast Oncology, Breast Cancer, Cancer Treatment +4

Endochin Optimization: Structure−Activity and Structure−Property Relationship Studies of 3-Substituted 2-Methyl-4(1<i>H</i>)-quinolones with Antimalarial Activity

R. Matthew Cross, Andrii Monastyrskyi, Tina Mutka et al. · Journal of Medicinal Chemistry · 2010 · 101 citations

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells

Kamira Maharaj, John J. Powers, Alex Achille et al. · Blood Advances · 2020 · 62 citations · Full text

Cll Treg Number, Mixed-phenotype Acute Leukemia, Immunology +21

Metal-Free Arylation of Ethyl Acetoacetate with Hypervalent Diaryliodonium Salts: An Immediate Access to Diverse 3-Aryl-4(1<i>H</i>)-Quinolones

Andrii Monastyrskyi, Niranjan K. Namelikonda, Roman Manetsch · The Journal of Organic Chemistry · 2015 · 53 citations · Full text

Clean Arylation Protocol, Medicinal Chemistry, Cross-coupling Reaction +15

Orally Bioavailable 6-Chloro-7-methoxy-4(1<i>H</i>)-quinolones Efficacious against Multiple Stages of <i>Plasmodium</i>

R. Matthew Cross, David L. Flanigan, Andrii Monastyrskyi et al. · Journal of Medicinal Chemistry · 2014 · 39 citations · Full text